Atlas Trials

131I-MIBG With Myeloablative Chemotherapy and Autologous Stem Cell Transplantation for the Treatment of High-risk Neuroblastoma

Clinical trial NCT00798148 · UNKNOWN

Trial details

NCT number
NCT00798148
Sponsor
Tehran University of Medical Sciences
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Neuroblastoma
Start date
2008-09-01
Primary completion
2012-07-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.